Příspěvky

Zobrazují se příspěvky z květen, 2014

Delaying ADT Safe for Prostate Cancer Patients | Cancer Network

Obrázek
Delaying ADT Safe for Prostate Cancer Patients | Cancer Network



The estimated 5-year overall survival among the group of men who had delayed ADT was 87.2% compared with 85.1% for those who had immediate ADT following a PSA-based relapse. Ten-year survival was 71.6% for both groups. The prostate cancer-specific mortality was also similar for the two groups: the 5-year survival for the immediate and delayed ADT groups was 96% and 93.3%, respectively, and the 10-year survival was 90.2% and 89.4%, respectively. All of the patients were previously treated with radical prostatectomy or radiotherapy......




....
Related articlesProstate Cancer Patients Who Opt for ADT Should also Undergo Counseling for Improving Mental and Emotional Well-BeingWhen undergoing androgen deprivation therapy, prostate cancer patients should be counseled to improve mental and emotional well-beingPrimary Androgen-Deprivation Therapy Has No Survival Benefit in Cancers Confined to ProstateMemory, thinking, concentration…